Dihydromyricetin reverses cognitive dysfunction in type 2 diabetic rats via inhibition of the JNK-ERS axis

Journal of Chinese Pharmaceutical Sciences · Published 2025-11-10 · DOI 10.5246/jcps.2025.11.075

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.5246/jcps.2025.11.075

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Global research trends on Phyllanthus emblica: a bibliometric and visual analysis from 1993 to 2024 · Journal of Chinese Pharmaceutical Sciences · 2026 · Same journal
• Quantification of Voriconazole in rat plasma using HPLC and pharmacokinetic analysis · Journal of Chinese Pharmaceutical Sciences · 2025 · Same journal
• Optimizing immunosuppressant regimens and therapeutic drug monitoring in solid organ transplant recipients with COVID-19: A multicenter retrospective study · Journal of Chinese Pharmaceutical Sciences · 2025 · Same journal
• Unveiling the mechanisms of Bidentate Achyranthes and American Ginseng therapy in Sjögren’s Syndrome: insights from network pharmacology and molecular docking · Journal of Chinese Pharmaceutical Sciences · 2025 · Same journal
• Xuebijing injection for sepsis-associated acute kidney injury treatment: a systematic review and meta-analysis · Journal of Chinese Pharmaceutical Sciences · 2025 · Same journal
• Effects of storage temperature on the quality stability of nanoparticle aluminum hydroxide adjuvant · Journal of Chinese Pharmaceutical Sciences · 2025 · Same journal
• Development of an evaluation index system for calcium channel blockers in healthcare institutions · Journal of Chinese Pharmaceutical Sciences · 2026 · Same journal
• Current Issue Archive 02 December 2025, Volume 34 Issue 11Previous Issue Review Advancements in the therapeutic application of indoxyl sulfate for kidney injury management · Journal of Chinese Pharmaceutical Sciences · 2025 · Same journal
• Molecular docking and dynamics simulations reveal phytosterol mechanisms in chronic kidney disease therapy · Journal of Chinese Pharmaceutical Sciences · 2026 · Same journal
• Baicalein attenuates neuroinflammation in thrombotic stroke by downregulating the TLR4/MyD88/NF-κB signaling pathway · Journal of Chinese Pharmaceutical Sciences · 2026 · Same journal